What does CUSIP M47238106 represent in this 13F holders report?

CUSIP M47238106 is the security identifier for GLMD - GALMED PHARMACEUTICALS LTD - SHS used to aggregate holder disclosures.

How many institutions held GLMD - GALMED PHARMACEUTICALS LTD - SHS in Q4 2018?

42 institutional investors reported GLMD - GALMED PHARMACEUTICALS LTD - SHS for Q4 2018. Use the holders table for investor-level position and value details.

GALMED PHARMACEUTICALS LTD - SHS (GLMD)

CUSIP: M47238106

Q4 2018 13F Holders as of 31 Dec 2018

Security type / class: Equity / SHS
Total 13F shares: 7,647,947
Total 13F value: $52,233,830
Share change: +34,955
Put/Call ratio: 93%
SEC-reported price per share: $6.83
Number of holders: 42
Value change: -$1,016,802
Number of buys: 21
Number of sells: 17

Security key

M47238106

Report period

Q4 2018

Institutions

Top holders

GLMD full security history Ownership snapshot Full 13F holder table Galmed Pharmaceuticals Ltd. SEC filings Galmed Pharmaceuticals Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of GLMD - GALMED PHARMACEUTICALS LTD - SHS (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BVF INC/IL

Disclosed value leader

BVF INC/IL

Comparable rows

0/15

Latest evidence

30 Sep 2018

13F Highest disclosed value: $23,922,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BVF INC/IL has the largest disclosed position value at $23.92M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BVF INC/IL's linked filing trail.

Disclosed position value Top 5

BVF INC/IL $23.92M

683 Capital Management, LLC $18.33M

Vivo Capital, LLC $11.56M

Nantahala Capital Management, LLC $11.39M

MEITAV INVESTMENT HOUSE LTD $8.95M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BVF INC/IL	13F Company 13F	— denominator unverified	$23,922,000 1,761,567 shares	—	30 Sep 2018
683 Capital Management, LLC	13F Company 13F	— denominator unverified	$18,333,000 1,350,000 shares	—	30 Sep 2018
Vivo Capital, LLC	13F Company 13F	— denominator unverified	$11,563,000 851,492 shares	—	30 Sep 2018
Nantahala Capital Management, LLC	13F Company 13F	— denominator unverified	$11,389,000 838,674 shares	—	30 Sep 2018
MEITAV INVESTMENT HOUSE LTD	13F Company 13F	— denominator unverified	$8,946,000 653,957 shares	—	30 Sep 2018
IBEX INVESTORS LLC	13F Company 13F	— denominator unverified	$5,676,000 418,000 shares	—	30 Sep 2018

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

7,647,947

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders

Q4 2018 holders

Holder diff

Investor	Q3 2018 Shares	Q4 2018 Shares	Share Diff	Share Chg %	Q3 2018 value	Q4 2018 value	Value change	Value Chg %